Streetbeat News

Products Services

SKYQ

Sky Quarry has partnered with Atlas Roofing to explore recycling processes for waste asphalt shingle material and oil. This partnership aims to develop mutually beneficial methods for material recovery.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:33 pm

YOSH

Yoshiharu Global has partnered with Chengdu Octaday Entertainment Group to expand its cuisine offerings in Sichuan Province, China. This agreement aims to broaden Yoshiharu's international presence by introducing its cuisine in multiple hotel locations.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:33 pm

CMG

Chipotle's Cultivate Next Fund has invested in AI supply chain platform Lumachain and Mediterranean-inspired fast-casual concept Brassica. These investments aim to enhance food production and support Chipotle's growth towards 7,000 restaurants.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:33 pm

DGX

Quest Diagnostics has launched a new self-collection service for testing common genital tract infections at its 2,000 patient service centers. This service aims to provide more convenient and discreet access to testing and treatment.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:32 pm

TBLA

Taboola has launched Abby, a new generative AI assistant designed to help advertisers start and manage campaigns using conversational AI. This innovation aims to streamline the advertising process and enhance user experience.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:31 pm

OKLO

The Department of Energy (DOE) has approved the Conceptual Safety Design Report for Oklo's Aurora Fuel Fabrication Facility. This approval advances Oklo's plans to utilize recovered nuclear material for its first commercial powerhouse.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:27 pm

ARDX

Ardelyx, Inc. will present additional data on XPHOZAH, a first-in-class phosphate absorption inhibitor for adults with chronic kidney disease on dialysis, at the American Society of Nephrology's Kidney Week in October 2024.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:26 pm

ALT

Altimmune, Inc. will present new data on the lipidomic profile of subjects treated with pemvidutide at The Liver Meeting 2024. The data shows reductions in atherogenic and cardio-inflammatory lipids from a Phase 1b study. A Phase 2b trial is ongoing with results expected in Q2 2025.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:26 pm

MNPR

Monopar Therapeutics Inc. has filed a provisional patent for new therapeutic radiopharmaceuticals, enhancing their intellectual property portfolio. The patent covers a family of linkers that improve stability and biodistribution of radiopharmaceuticals, including their uPAR targeting antibody MNPR-101.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:25 pm

VTYX

Ventyx Biosciences presented 52-week results from their Phase 2 trial of VTX002 (Tamuzimod) for treating ulcerative colitis at UEG Week 2024 in Vienna. This development could impact the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 12:24 pm